About Ventana Biotech, Inc.
Sector
Industry
CEO
Stephen D. Replin
Headquarters
Denver
Founded
1989
FIGI
BBG000BBR0Q4
Ventana Biotech, Inc. is a bioscience company, which engages in identifying, evaluating, acquiring, developing, and partnering to achieve commercialization of intellectual property in the area of drug candidates for personalized medicine. It focuses on the areas of anti-obesity and related illnesses. The company was founded on November 6, 1989 and is headquartered in Denver, CO.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VNTA is 0.0030 USD — it has increased by 15.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ventana Biotech, Inc. stocks are traded under the ticker VNTA.
VNTA stock is 16.33% volatile and has beta coefficient of 2.25. Check out the list of the most volatile stocks — is Ventana Biotech, Inc. there?
Yes, you can track Ventana Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
VNTA stock has risen by 1.69% compared to the previous week, the month change is a 42.86% rise, over the last year Ventana Biotech, Inc. has showed a 15.38% increase.
No, VNTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VNTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ventana Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ventana Biotech, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ventana Biotech, Inc. stock shows the neutral signal. See more of Ventana Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.